Showing results (11-20 of 264) with videos related to
Sort By:
Pageof 27
Metabolism: Clinical and Experimental|May 1, 1990
Splanchnic removal of human alpha-atrial natriuretic peptide in humans: enhancement after food intakeJ H Henriksen, F Bendtsen, A L GerbesAlimentary Pharmacology & Therapeutics|November 9, 2002
Review article: volume expansion in patients with cirrhosisJ H Henriksen, M Kiszka-Kanowitz, F BendtsenScandinavian Journal of Clinical and Laboratory Investigation|October 1, 1993
Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockadeF Bendtsen, A L Gerbes, J H HenriksenLiver|June 1, 1987
Hepatic venous oxygen content in alcoholic cirrhosis and non-cirrhotic alcoholic liver diseaseF Bendtsen, J H Henriksen, A Widding, et al.Ugeskrift for Laeger|September 25, 1995
[Prediction of bleeding risks and death in cirrhosis based on hemodynamic and metabolic variables. A study of patients with esophageal varices without previous bleeding]S Møller, F Bendtsen, E Christensen, et al.Metabolism: Clinical and Experimental|January 26, 2000
Increased circulating calcitonin in cirrhosis. Relation to severity of disease and calcitonin gene-related peptideJ H Henriksen, S Schifter, S Møller, et al.Scandinavian Journal of Gastroenterology|September 1, 1996
Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosisS Møller, F Bendtsen, S Schifter, et al.Journal of Hepatology|December 1, 1994
Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleedingS Møller, F Bendtsen, E Christensen, et al.Journal of Hepatology|November 7, 1999
Increased arterial compliance in decompensated cirrhosisJ H Henriksen, S Møller, S Schifter, et al.Gut|February 14, 2006
Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamicsJ H Henriksen, S Fuglsang, F Bendtsen, et al.Pageof 27